Publications by authors named "Walter Kolch"

Introduction: Mathematical models are powerful tools that can be used to advance our understanding of complex diseases. Autoimmune disorders such as systemic lupus erythematosus (SLE) are highly heterogeneous and require high-resolution mechanistic approaches. In this work, we present ONIDsc, a single-cell regulatory network inference model designed to elucidate immune-related disease mechanisms in SLE.

View Article and Find Full Text PDF

Background: Molecular diagnostics are critical for informing cancer patient care. In Ireland, the National Cancer Control Programme (NCCP) develops cancer therapy regimens, which include relevant information on molecular indications. Here, we present a collated overview of the current molecular indications of all NCCP systemic anti-cancer therapy regimens and the funding statuses of their associated drugs.

View Article and Find Full Text PDF

Introduction: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been a major health emergency since its emergence in late 2019. Endothelial dysfunction is a hallmark of COVID-19, leading to severe illness, i.e.

View Article and Find Full Text PDF

Patients with high-grade serous ovarian cancer (HGSOC) typically present with widespread metastasis, obscuring a temporal understanding of tumor-immune dynamics. To address this, we perform multi-site global proteomics alongside matched immunohistochemistry (IHC) for CD4⁺ and CD8⁺ tumor-infiltrating lymphocytes (TILs) in patient samples. We order the protein expression profiles using an unbiased pseudotime analysis, recapitulating clinical observations of metastatic progression, and providing a framework to explore tumor-immune dynamics from localized to metastatic disease.

View Article and Find Full Text PDF

Background: Ethnic minority communities are often recognised as experiencing decreased accessibility to vital medical services as well as increased barriers to participation in research studies. These issues stem from a variety of social, cultural and economic factors, all of which must be taken into consideration when designing engagement initiatives for a particular community. Invisible Spectrum is an annual engagement initiative which seeks to promote effective communication and outreach to often-overlooked ethnic minority communities within Ireland, primarily those of Bangladeshi origin.

View Article and Find Full Text PDF

The tumour microenvironment is composed of a complex cellular network involving cancer, stromal and immune cells in dynamic interactions. A large proportion of this network relies on direct physical interactions between cells, which may impact patient responses to clinical therapy. Doublets in scRNA-seq are usually excluded from analysis.

View Article and Find Full Text PDF

The eIF4F translation initiation complex plays a critical role in melanoma resistance to clinical BRAF and MEK inhibitors. In this study, we uncover a function of eIF4F in the negative regulation of the rat sarcoma (RAS)/rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase (MAPK) signaling pathway. We demonstrate that eIF4F is essential for controlling ERK signaling intensity in treatment-naïve melanoma cells harboring or mutations.

View Article and Find Full Text PDF

In severe Placenta Accreta Spectrum (PAS), trophoblasts gain deep access in the myometrium (placenta increta). This study investigated alterations at the fetal-maternal interface in PAS cases using a systems biology approach consisting of immunohistochemistry, spatial transcriptomics and proteomics. We identified spatial variation in the distribution of CD4, CD3 and CD8 T-cells at the maternal-interface in placenta increta cases.

View Article and Find Full Text PDF

Pancreatic ductal adenocarcinoma (PDAC) presents significant challenges for targeted clinical interventions due to prevalent KRAS mutations, rendering PDAC resistant to RAF and MEK inhibitors (RAFi and MEKi). In addition, responses to targeted therapies vary between patients. Here, we explored the differential sensitivities of PDAC cell lines to RAFi and MEKi and developed an isogenic pair comprising the most sensitive and resistant PDAC cells.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigated how the protein expression of NT2 embryonal carcinoma cells changes when treated with retinoic acid, indicating differentiation from a pluripotent state.
  • Mass spectrometry was used to analyze over 5,000 proteins, revealing significant alterations in chromatin proteins and the regulation of epigenetic pathways during this process.
  • The research found a connection between cathepsin proteases and histone modifications, showing that inhibiting these proteases decreases histone H3 clipping, which is important for gene expression changes linked to cell differentiation.
View Article and Find Full Text PDF

T cell co-inhibitory immune checkpoints, such as PD-1 or BTLA, are bona fide targets in cancer therapy. We used a human T cell reporter line to measure transcriptomic changes mediated by PD-1- and BTLA-induced signaling. T cell receptor (TCR)-complex stimulation resulted in the upregulation of a large number of genes but also in repression of a similar number of genes.

View Article and Find Full Text PDF
Article Synopsis
  • The study explores how to understand and control cell behaviors, particularly in breast cancer, using a technique called cSTAR to analyze single-cell signaling patterns.
  • Researchers found distinct signaling networks in different breast cancer subtypes, with mTOR being a key driver in luminal cancers, while basal cancers had varied networks with multiple drivers.
  • The developed cSTAR models act as digital twins of cells, helping to manipulate cell transitions and suggesting ways to normalize cancer cell signaling with small molecule inhibitors.
View Article and Find Full Text PDF

Early-onset colorectal cancer (EOCRC), defined as colorectal cancer in individuals under 50 years of age, has shown an alarming increase in incidence worldwide. We report a case of a twenty-four-year-old female with a strong family history of colorectal cancer (CRC) but without an identified underlying genetic predisposition syndrome. Two years after primary surgery and adjuvant chemotherapy, the patient developed new liver lesions.

View Article and Find Full Text PDF

Unlabelled: Racial disparities between Black/African Americans (AA) and White patients in colorectal cancer are an ever-growing area of concern. Black/AA show the highest incidence and have the highest mortality among major U.S.

View Article and Find Full Text PDF
Article Synopsis
  • Mesenchymal stem/stromal cells (MSCs) can differentiate into chondrocytes, which are the cells needed for cartilage repair, but this process is complicated and takes over three weeks.
  • The researchers conducted transcriptional profiling of MSCs differentiating into chondrocytes at various early timepoints (15 minutes to 16 hours) and at full differentiation (21 days) to better understand the initial phases of this process.
View Article and Find Full Text PDF
Article Synopsis
  • RAS proteins play essential roles in cell signaling, affecting processes like cell growth, specialization, and death, with KRAS being a notable member commonly mutated in cancers.
  • Recent research indicates that not all KRAS mutants are always active, leading to the development of treatments like KRASG12C inhibitors, although resistance remains a challenge.
  • The study employs advanced mass-spectrometry proteomics to analyze the interactions of KRAS variants, revealing important insights into KRAS signaling networks and identifying new connections to other signaling pathways, which could aid in creating better-targeted therapies.
View Article and Find Full Text PDF
Article Synopsis
  • KSR1 is a scaffolding protein involved in the RAS-RAF-MEK-ERK signaling pathway, which is often altered in cancers and plays a role in mutant RAS-mediated transformation.
  • Research shows that when KSR1 is knocked out in BRAFV600E-transformed melanoma cells using CRISPR/Cas9, it leads to issues like slower growth, defects in the cell cycle, and increased cell death.
  • The study indicates that KSR1 helps ERK phosphorylate proteins that promote cell survival; without KSR1, there's activation of another pathway (p38 MAPK) that contributes to these negative effects.
View Article and Find Full Text PDF
Article Synopsis
  • The rapid growth of omics data is not matched by our ability to effectively use this information to control cell behaviors and reverse diseases.* -
  • Core networks, which link genetic information to observable traits (phenotype), are essential for understanding how to change cell states and steer their decisions.* -
  • The cSTAR method uses perturbation biology to create digital models of cells that help us understand how to revert cancerous changes back to normal cell functions.*
View Article and Find Full Text PDF
Article Synopsis
  • Single-cell technologies have advanced the understanding of immune responses to checkpoint inhibitors, but bulk RNA sequencing (RNA-seq) is more practical for clinical diagnostics.
  • The research developed a method using transcription factor-directed coexpression networks (regulons) from single-cell data to analyze immune cell states in bulk RNA-seq, revealing four key cell states linked to treatment response in melanoma patients.
  • The study showed that the interaction between exhausted T cells and monocyte lineage cells affects patient prognosis, with monocytes potentially driving T cells into a state of exhaustion, highlighting the importance of regulon-based analysis for identifying responders to immune therapy.
View Article and Find Full Text PDF
Article Synopsis
  • - RAF kinases are significant contributors to cancer development, particularly through mutations like BRAFV600E, which are found in approximately 6% of human cancers.
  • - Although there are effective kinase inhibitors, their effects can vary across different cancer types, and they can sometimes lead to paradoxical activation of RAF kinases due to increased dimerization between RAF1 and BRAF, which keeps the MEK-ERK signaling pathway active.
  • - The study used quantitative proteomics to analyze over 1,000 proteins in relation to different RAF dimer formations and the effects of two clinically used RAF inhibitors, revealing both common and unique interactions that could help explain resistance to these drugs.
View Article and Find Full Text PDF

Gene expression noise is known to promote stochastic drug resistance through the elevated expression of individual genes in rare cancer cells. However, we now demonstrate that chemoresistant neuroblastoma cells emerge at a much higher frequency when the influence of noise is integrated across multiple components of an apoptotic signaling network. Using a JNK activity biosensor with longitudinal high-content and in vivo intravital imaging, we identify a population of stochastic, JNK-impaired, chemoresistant cells that exist because of noise within this signaling network.

View Article and Find Full Text PDF
Article Synopsis
  • Hidradenitis suppurativa (HS) is a complex skin condition that's tough to treat, with adalimumab being the only approved therapy and only helping about 50% of patients.
  • The study investigated differences in gene expression between affected (lesional) and unaffected (nonlesional) skin in HS patients before and after 12 weeks of adalimumab treatment, aiming to uncover potential biomarkers for treatment response.
  • Findings suggest significant immune system involvement in HS, with certain genes indicating treatment response and disease severity, pointing towards the need for personalized treatment strategies targeting specific immune pathways.
View Article and Find Full Text PDF

Early onset colorectal cancer (EOCRC), defined as colorectal cancers in patients aged less than 50 years, is becoming an increasingly common issue, globally. Since 1994, the incidence of this condition has been rising by 2% annually. Approximately one in five patients under 50 years of age diagnosed with colorectal cancer have an underlying genetic predisposition syndrome.

View Article and Find Full Text PDF